SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-043233
Filing Date
2024-04-04
Accepted
2024-04-03 19:33:24
Documents
21
Period of Report
2024-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2410784d1_8k.htm   iXBRL 8-K 97227
2 EXHIBIT 2.1 tm2410784d1_ex2-1.htm EX-2.1 1110430
3 EXHIBIT 3.1 tm2410784d1_ex3-1.htm EX-3.1 83995
4 EXHIBIT 3.2 tm2410784d1_ex3-2.htm EX-3.2 7949
5 EXHIBIT 10.1 tm2410784d1_ex10-1.htm EX-10.1 257694
6 EXHIBIT 10.2 tm2410784d1_ex10-2.htm EX-10.2 167147
7 EXHIBIT 10.3 tm2410784d1_ex10-3.htm EX-10.3 98423
8 EXHIBIT 10.4 tm2410784d1_ex10-4.htm EX-10.4 15580
9 EXHIBIT 99.1 tm2410784d1_ex99-1.htm EX-99.1 36065
  Complete submission text file 0001104659-24-043233.txt   2492813

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA traw-20240401.xsd EX-101.SCH 3015
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE traw-20240401_lab.xml EX-101.LAB 34916
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE traw-20240401_pre.xml EX-101.PRE 22789
24 EXTRACTED XBRL INSTANCE DOCUMENT tm2410784d1_8k_htm.xml XML 3847
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 24820956
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)